These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4142946)

  • 1. [Clinical plasma substitution with gelatin: A 12-year experience with 39,320 units of Physiogel].
    Tschirren B; Affolter U; Elsässer R; Frehofer UA; Grawehr R; Müller PH; Lundsgaard-Hansen P
    Infusionstherapie (1973); 1974 Dec; 1(8):651-62. PubMed ID: 4142946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Practical experience with Physiogel as blood substitute].
    Tschirren B; Pfistner P
    Helv Chir Acta; 1966 May; 33(3):404-14. PubMed ID: 5994660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of blood substitution of equal volume by a higher-molecular gelatine preparation following hypotension induced by blood withdrawal].
    Hölscher B
    Arzneimittelforschung; 1970 Dec; 20(12):1901-4. PubMed ID: 5537093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy about plasma substitutes].
    Cron TA; Gerber H
    Schweiz Med Wochenschr; 1991 Nov; 121(48):1773-6. PubMed ID: 1688371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side-effects in volume substitution using gelatin preparations].
    Schmidt H; Pflüger H
    Med Welt; 1971 Jun; 26():1073-7. PubMed ID: 5088982
    [No Abstract]   [Full Text] [Related]  

  • 6. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiogel. Chemical and physio-chemical properties].
    Beutl K; Roggen G; Nitschmann H
    Helv Chir Acta; 1966 May; 33(3):343-7. PubMed ID: 5994655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of gelofusin in the clinics of the St. Petersburg's I.P. Pavlov State Medical University].
    Baryshev BA; Doĭnikov DN; Khabarova IG; Kovalev MG
    Vestn Khir Im I I Grek; 1998; 157(2):51-4. PubMed ID: 9691382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Succinate-polymerized gelatin as a plasma substitute].
    Tosaki Y; Yasusumi N; Takaori M; Matsuki H; Okumura M
    Nihon Rinsho; 1968 May; 26(5):1227-33. PubMed ID: 5749805
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with 120,000 units of modified fluid gelatin.
    Lundsgaard-Hansen P; Tschirren B
    Dev Biol Stand; 1980; 48():251-6. PubMed ID: 7274558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the efficacy and tolerability of 2 plasma substitutes used as vascular-loading solutions during plasma exchange].
    Bombail-Girard D; Boulechfar H; Tangre M; Landillon N; Bussel A
    Ann Med Interne (Paris); 1990; 141(7):611-4. PubMed ID: 2085241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of plasma expanders in cases without blood transfusion, with special reference to Gelofusine].
    Ishii Y; Kuwano K; Maruyama K; Yokoyama T; Sawano Y
    Shujutsu; 1968 Apr; 22(4):466-73. PubMed ID: 5698869
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of intravascular volume deficiency. Clinical experience report on Haemaccel].
    Schäfer H
    Med Klin; 1967 Dec; 62(51):1992-5. PubMed ID: 5595353
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gelatin allergy].
    Hassoun S; Sabbah A
    Allerg Immunol (Paris); 1998 Mar; 30(3):80-2. PubMed ID: 9582941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a hydroxyethylstarch solution on plasma colloid osmotic pressure in acutely ill patients.
    Mbaba Mena J; De Backer D; Vincent JL
    Acta Anaesthesiol Belg; 2000; 51(1):39-42. PubMed ID: 10806521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies on modified fluid gelatin as a plasma substitute. 1].
    Tosaki Y; Asumi N; Takaori M
    Masui; 1968 Apr; 17(4):323-30. PubMed ID: 5692009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy with volume-substitution solutions].
    Lutz H; Peter K
    Z Prakt Anasth; 1971 Aug; 6(4):276-81. PubMed ID: 4259553
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood volumes, plasma volumes and total plasma albumin after human blood-loss substitution with physiogel, macrodex 6 and 1,8 dextran-Ringer-lactate].
    Schaer H; Kundert HP; Hossli G
    Bibl Haematol; 1971; 37():329-35. PubMed ID: 5138918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of a modified gelatin polymer in the control of hypovolemia. Application to hemodialysis].
    Haibach L; Baubeau D; Jahn H
    Anesth Analg (Paris); 1976; 3(4):673-89. PubMed ID: 1015655
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anaphylactic reaction resulting from the administration of gelatin-base plasma expanders].
    Meisel G; Zöckler H
    Bibl Haematol; 1971; 37():348-53. PubMed ID: 5138921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.